SouthState’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
SouthState's DXCM Position: Q3 2026 in Review
SouthState increased its DexCom (DXCM) stake by 30% in Q3 2026, buying an estimated $582 and bringing the position to 30 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #929.
SouthState first reported a position in DXCM in Q3 2023 and has held it in 12 quarters since. The position peaked at $82K in Q1 2024. 868 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- SouthState held 30 shares of DexCom worth $2.59K as of Q3 2026.
- SouthState bought 7 DexCom shares in Q3 2026, an estimated $582.
- DexCom made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #929 holding.
- SouthState first reported a position in DexCom in Q3 2023 and has held it in 12 quarters since.
- SouthState's DexCom position peaked at $82K in Q1 2024.
- 868 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.